AKE.PA
T3Arkema S.A.
OverviewArkema S.A. manufactures specialty chemicals and advanced materials globally. Starting in 2026, it operates through Specialty Materials, focusing on resilient,
Arkema S.A. manufactures specialty chemicals and advanced materials globally. Starting in 2026, it operates through Specialty Materials, focusing on resilient, fast-growing platforms like batteries and 3D printing, and Primary Materials, comprising more cyclical industrial activities including polyamides and acrylics. The company serves diverse sectors such as construction, automotive, electronics, and consumer goods.
- What They Do (Plain English & Analogies)
- Arkema makes the chemical ingredients and specialty materials that other manufacturers use to build finished products. Think of Arkema as a supplier of “high‑performance building blocks” for industry: it supplies the sticky glue and sealants that keep windows, floors and packaging together (Bostik), the advanced plastics and polymers used inside electric vehicles, smartphones and 3D‑printed parts (Rilsan, PVDF), and a range of coated resins, additives and fluorochemicals used in refrigeration, electronics and paints. An analogy: if a car or a phone is a cake, Arkema supplies the special flours, emulsifiers and glazes — not the whole cake, but the technical ingredients that make the cake hold together, perform, and survive tough conditions. They mix commodity chemical businesses (big, cyclical raw materials) with higher‑margin, innovation‑driven specialty materials that serve fast‑growing applications like batteries, advanced electronics and sustainable consumer goods.
- Very Brief History
- Arkema was created as an independent company in the early 2000s from parts of Total's chemicals activities and has since transformed from a commodity chemical producer into a specialty chemicals and advanced materials group through acquisitions (notably Bostik, Sartomer, Coatex and downstream assets) and organic investments. Over the past decade it has ramped up high‑value polymers (Rilsan PA11, PVDF), integrated adhesive businesses (Bostik), and expanded global production footprint in the U.S. and Asia.
- "Street Stereotype"
- Investors generally view Arkema as a mid‑cap specialty chemicals company in transition: a hybrid mix of steady, cash‑generating commodity products (acrylics, some intermediates, polyamides) and higher‑growth specialty platforms (adhesives, high‑performance polymers, fluorospecialties). The street appreciates its R&D and niche positions (battery materials, PVDF, polyamide 11) but worries about cyclicality in upstream businesses (acrylics, old refrigerants), FX volatility and sensitivity to manufacturing cycles.
- Subsidiaries On Linked In*
- Common Arkema subsidiary/brand pages observed on LinkedIn include: Bostik; Sartomer; Coatex; Rilsan (Arkema Rilsan or product pages); Kynar/Kynar PVDF (Arkema product pages). Note: exact LinkedIn subsidiary pages and naming vary by region; some brand pages are product‑focused rather than legally separate companies.
- Customer Sectors & Example Clients
- Sectors: automotive & EV manufacturers (OEMs and tier‑1s), electronics & smartphones, batteries and battery makers, construction & building materials, paints & coatings manufacturers, packaging, healthcare & medical devices, aerospace, industrial equipment, refrigeration/ HVAC. Example clients (educated, high‑probability matches based on Arkema's products): OEMs and suppliers such as Stellantis, BMW, Tesla (polymers, adhesives), battery makers like LG Energy Solution, SK On, CATL and Panasonic (PVDF, binder/fluoropolymers), electronics firms and tier‑1s such as Samsung and Apple (high‑performance polymers for thermal management and flexible devices), coating & paint companies such as PPG and AkzoNobel (acrylics and resins), and major packaging firms like Amcor and Sealed Air (adhesives, polymers). These client names are plausible given Arkema's product set but are not all explicitly named in the transcript.
- New Customers / Segments They'Re Targeting
- Arkema is explicitly targeting high‑growth segments: battery materials (for EVs and energy storage), electronics (advanced polymers for foldable/ultra‑slim smartphones, thermal management and advanced electronics), 3D printing, sports/apparel composites, healthcare materials, and next‑generation fluorospecialties (low‑GWP refrigerant solutions and fluoropolymers for data centers and heat pumps). Geographically they are targeting more business in Asia (China) and the U.S. through recent investments — i.e., upstream specialty customers and OEMs in EVs, advanced electronics and sustainable consumer goods.
- Supply Chain And Sourcing Geographies
- High‑confidence supply footprint: Arkema operates production and R&D sites in Europe (headquartered in Colombes, France), North America (multiple U.S. sites including new U.S. PVDF capacity), and Asia (notably a polyamide 11 plant and downstream Rilsan Clear capacity in Singapore; strong commercial presence in China and other Asian markets). Primary feedstocks include petrochemical monomers (acrylics, propylene derivatives), fluorine‑based inputs for PVDF and refrigerants, and specialty intermediates (thiochemicals, peroxides). Sourcing geography notes/uncertainty: the transcript confirms investments in the U.S. and Singapore and strong sales momentum in China; exact country origins for raw feedstocks (e.g., which refineries or suppliers) are not disclosed in the transcript and may vary by product line. Confidence: high for production footprint (France/Europe, U.S., Singapore, China); moderate for specific raw‑material supplier origins.
- Sales Geographies And Expansion Plans
- Arkema sells globally with material exposure to Europe, North America and Asia. Management says Asia — especially China — was the most dynamic region in 2025 (higher demand in EVs, electronics, sustainable consumer goods). Europe and North America saw subdued demand in 2025, with the U.S. weakening in H2. Expansion/plans: management is investing to strengthen U.S. and Asian manufacturing (new U.S. PVDF unit starting H1 2026, downstream Rilsan capacity in Singapore, new U.S. DMDS and 1233zd units), signaling continued focus on growing presence in North America and Asia.
- How Key Themes May Help/Hurt
- Help: The buildout of electronic chemicals and electrification benefits Arkema's high‑performance polymers (PVDF binders and fluoropolymers), specialty polyamides (Rilsan PA11 for thermal/structural parts), and adhesives for advanced electronics and batteries. Demand from data centers, EV batteries and advanced consumer electronics supports pricing power and long qualification cycles, which rewards established suppliers. Hurt: Theme risks include cyclical weakness in end markets (if device OEMs or EV makers cut capex), qualification timelines (long lead times before new materials become standard), and increased competition/overcapacity as peers and new entrants scale similar specialty materials. Also, Arkema's remaining commodity exposures (acrylics, old‑generation refrigerants, some intermediates) can blunt consolidated results during industrial downturns even if high‑value segments grow.
3 Main Long-Term Bull Details
- Strategic exposure to high‑growth niches: Leading positions in PVDF, PA11 (Rilsan) and adhesives give Arkema direct exposure to batteries, advanced electronics and lightweight composites — markets with multi‑year structural growth. 2) Strong cash generation and disciplined capital allocation: recent high cash conversion (EUR 464m recurring cash flow in 2025; EBITDA‑to‑cash conversion ~88%), manageable net leverage (~2.5x net debt/EBITDA reported), and a focused 2026 CapEx reduction to ~EUR 600m improve flexibility for dividends and targeted growth. 3) Innovation and sustainability roadmap: R&D and partnerships (low‑GWP refrigerants, carbon capture links) support differentiated products with higher returns and align with regulatory tailwinds favoring low‑carbon, high‑performance materials.
3 Main Long-Term Bear Details
- Portfolio cyclicality/commodity exposure: Significant earnings volatility from acrylics, some intermediates and old‑generation refrigerants can depress consolidated results even if specialties grow. 2) Macro, FX and inventory risk: Weak manufacturing cycles, global destocking and currency headwinds (noted USD and Asian currency weakness vs EUR) materially affect sales and EBITDA; Arkema called out a EUR 25m negative FX headwind in Q1 2026. 3) Execution and competition risks: Major project ramp‑ups (PVDF, U.S./Asia expansions) face timing, qualification and execution risk; increased competition or capacity additions by peers could pressure margins in specialist products over time.
- Competitors And Differentiation
- Competitors: major diversified chemical and specialty players such as BASF, Evonik, Solvay, DuPont, Clariant, LANXESS, Henkel (adhesives), H.B. Fuller (adhesives), and regional commodity producers in acrylics and intermediates. Differentiation: Arkema leans on product differentiation (high‑performance polymers like Rilsan PA11 and PVDF/Kynar), application‑specific R&D and customer proximity, targeted project investments to serve batteries and electronics, and a sustainability angle (low‑GWP fluorospecialties). Its strategy is to pair commodity cash generators with higher‑margin, innovation‑led specialty platforms and to leverage R&D and partnerships (e.g., batteries, carbon‑capture collaborations) to secure long‑term niche positions.
- Recent Performance & What The Market'S Focused On
- 2025 results (reported Feb 26, 2026): revenues ~EUR 9.1bn; EBITDA ~EUR 1.25bn (13.8% margin); recurring EBIT ~EUR 564m; adjusted net income EUR 328m (EUR 4.34/sh); recurring cash flow EUR 464m (above guidance); free cash flow EUR 390m; net debt including hybrids ~EUR 3.2bn (net debt/EBITDA ~2.5x); proposed dividend EUR 3.60/share. Management delivered ~EUR 90m of cost savings in 2025 and expects to reach cumulative EUR 250m by 2028 ahead of schedule. Market focus areas: the new 2026 segmentation (Specialty Materials vs Primary Materials) and its transparency implications; project ramp‑ups (PVDF US start‑up H1 2026, Rilsan downstream Singapore, US 1233zd and DMDS units); acrylics and refrigerant cycles; cash conversion & working capital (working capital ratio 12.5% of sales); FX impact and guidance of slight EBITDA growth at constant FX for 2026; capex guidance ~EUR 600m for 2026. Investors are watching whether specialty growth and project contributions offset cyclicality and FX pressure.
- Brands And Revenue Segments
- Key brands (product/market brands commonly associated with Arkema; some are marketed business names): Bostik (adhesives), Rilsan (PA11 polyamide), Kynar (PVDF/fluoropolymers; product family brand references), Sartomer (photocure/UV resins), Coatex (rheology additives and specialty resins), and product families in fluorospecialties and refrigerants. Revenue segments (historical and updated positioning): Prior reporting: Adhesive Solutions; Advanced Materials; Coating Solutions; Intermediates. From 2026 Arkema is reorganizing into: Specialty Materials (resilient, fast‑growing platforms: adhesives, advanced materials, fluorospecialties/new‑generation refrigerants, high‑performance polymers) and Primary Materials (more cyclical upstream activities: acrylics, old‑generation refrigerants, polyamides/upstream industrial activities). Approximate split (management commentary): Specialty Materials represents the large majority (~~85%) of the portfolio's strategic growth focus, while Primary Materials comprises a smaller, more cyclic portion (~~15%) — these proportions are approximate and based on management narrative rather than a published numeric restatement as of the call.
Bull / Bear DetailsArkema's investment thesis, updated March 7, 2026, centers on its strategic pivot to resilient Specialty Materials, driven by high-growth applications in batter
Thesis
Arkema's investment thesis, updated March 7, 2026, centers on its strategic pivot to resilient Specialty Materials, driven by high-growth applications in batteries, advanced electronics, and sustainable solutions. Despite a challenging macro, strong cash generation, accelerated cost savings, and ramp-up of key projects underpin future EBITDA growth. The new segmentation enhances transparency, though cyclical Primary Materials remain a drag, balancing the overall outlook.
Bull case
Arkema's strategic focus on high-growth Specialty Materials, particularly in advanced electronics, batteries, 3D printing, and new generation low GWP fluorospecialties, positions it for long-term growth. These segments benefit from strong market dynamics, including demand from electric mobility, advanced electronics, and sustainable consumer goods, driving sales growth and differentiation.
The company demonstrates strong operational execution, delivering high cash flow generation (EUR 464 million in 2025) and accelerating cost savings, with the 2028 cumulative target expected two years early. This financial discipline, combined with a stable dividend proposal, signals management's confidence and provides a solid foundation for slight EBITDA growth in 2026 at constant FX.
Arkema's ongoing major projects, including new 1233zd/DMDS units, Rilsan Clear capacity, and PVDF expansion, are strategically sound and continue to ramp up, contributing significant additional EBITDA (EUR 50 million expected in 2026). These investments reinforce geographical footprint in key growth regions like Asia and the U.S., supporting long-term development potential.
Bear case
The macroeconomic environment remains challenging with limited visibility and weak demand, continuing the difficult conditions experienced in 2025. This persistent headwind, coupled with expected more challenging year-on-year comparisons in H1 2026, particularly Q1, poses a significant risk to achieving anticipated slight EBITDA growth.
Arkema faces continued currency headwinds, with an estimated negative EUR 25 million impact in Q1 2026, which will dilute reported earnings. Furthermore, the newly segmented Primary Materials, particularly the upstream acrylics business, continues to experience a deep and prolonged cyclical downturn, impacting overall profitability and obscuring Specialty Materials performance.
While European authorities express awareness of industrial challenges, concrete actions to improve competitiveness and protect against unfair competition are currently lacking. Persistent destocking across the complex chemical supply chain, coupled with weak underlying demand, creates uncertainty regarding a sustained volume rebound and could further pressure pricing and margins.
Bull / Bear Case
- Bear Case
- The macroeconomic environment remains challenging with limited visibility and weak demand, continuing the difficult conditions of 2025. The chemical industry faces persistent overcapacity, soft demand, and global uncertainty, with production growth projected to slow in 2026. Arkema anticipates more challenging year-on-year comparisons in H1 2026, particularly Q1, and faces continued currency headwinds (estimated negative EUR 25 million impact in Q1 2026). The newly segmented Primary Materials, especially upstream acrylics, is experiencing a deep and prolonged cyclical downturn, impacting overall profitability. While European authorities express awareness of industrial challenges, concrete actions to improve competitiveness and protect against unfair competition are currently lacking. Persistent destocking and weak underlying demand create uncertainty for a sustained volume rebound.
- Bull Case
- Arkema is strategically pivoting towards high-growth Specialty Materials in advanced electronics, batteries, 3D printing, and new generation low GWP fluorospecialties, benefiting from strong market dynamics in electric mobility and sustainable consumer goods. The company demonstrates strong operational execution, generating high cash flow (EUR 464 million in 2025) and accelerating cost savings, with the 2028 cumulative target expected two years early. Management's confidence is underscored by a stable dividend proposal. Ongoing major projects, contributing EUR 50 million additional EBITDA in 2026, reinforce its geographical footprint in key growth regions like Asia and the U.S., supporting long-term development potential despite a challenging macro environment. The new segmentation aims to highlight the resilience of these core businesses.
- More Compelling & Why
- The Bear Case is more compelling. Arkema's current P/E ratio of 108.1x is significantly higher than the European Chemicals industry average of 17.7x, indicating overvaluation given its depressed earnings. The strongest argument is the persistent industry overcapacity and weak demand, which, combined with currency headwinds and a prolonged downturn in Primary Materials, poses substantial near-term risk to achieving even slight EBITDA growth in 2026. My view would flip if Arkema demonstrated a clear, sustained rebound in global chemical demand, particularly in Europe and U.S. industrial markets, leading to a significant and visible earnings recovery in H1 2026.
Key Factors
| Key Factor | Why It Matters | What To Watch | What It Signals | Where/How To Track | Free Alt Data | Paid Alt Data |
|---|---|---|---|---|---|---|
| Group EBITDA Growth at Constant FX | This factor directly reflects Arkema's overall financial health and its ability to navigate challenging macroeconomic conditions. Consistent growth at constant exchange rates indicates effective management and portfolio resilience, impacting investor confidence and the company's valuation. | Monitor Arkema's reported EBITDA growth at constant exchange rates for Q1 and H1 2026, as well as any updates to the full-year 2026 guidance. | Bullish: EBITDA growth significantly above 'slightly' at constant FX for 2026. Bearish: Flat or declining EBITDA at constant FX, or a downward revision of the 'slightly' growth target. | Company's quarterly and half-yearly earnings reports and conference calls. The next update will be for Q1 2026 results. | Industry reports from chemical associations (e.g., CEFIC) on overall sector performance and economic indicators for Europe and Asia. | Bloomberg Terminal: AKE.PA consensus EBITDA estimates vs. actuals; S&P Global Market Intelligence: Chemical industry peer performance analysis. |
| Construction End Market Demand (Europe & U.S.) | Construction is a significant end-market for Arkema's Adhesives and Coating Solutions segments. A rebound, particularly in Europe (from a perceived bottom) and the U.S. (after a H2 2025 decline), would signal improved demand and volume leverage for these businesses. | Listen for management's commentary on regional construction market trends (Europe, U.S.) in quarterly earnings calls, including insights into order books and customer discussions. | Bullish: Confirmation of sustained incremental improvement in European construction and a clear rebound in U.S. construction demand. Bearish: Continued subdued demand or further declines in either key region, impacting Adhesives and Coatings. | Company's quarterly earnings calls, particularly the Q&A sections regarding end-market commentary. Also, industry reports on construction activity. | Eurostat: EU construction output index; U.S. Census Bureau: Construction spending data; National Association of Home Builders (NAHB) Housing Market Index. | S&P Global Market Intelligence: Construction industry forecasts; Placer.ai: Foot traffic data for major DIY/home improvement retailers (indirect proxy for consumer construction activity). |
| Specialty Materials Segment Performance (Post-Segmentation) | The new segmentation aims to provide greater transparency and highlight the distinct dynamics of Arkema's resilient and fast-growing Specialty Materials. Its performance validates this strategic shift and the quality of the underlying portfolio, crucial for investor perception. | Monitor the organic growth rates, EBITDA margin, and management commentary on the resilience of the newly defined Specialty Materials segment in Q1 and H1 2026 earnings reports. | Bullish: Specialty Materials showing clear resilience (e.g., stable or growing EBITDA despite macro headwinds) and outperforming the Primary Materials segment. Bearish: Specialty Materials performance remains significantly impacted by macro factors, failing to demonstrate expected resilience. | Company's quarterly and half-yearly earnings reports, specifically the segment-level breakdown and management's discussion of the new structure. | Industry reports on specialty chemical market trends, particularly in high-growth areas like batteries, 3D printing, healthcare, and advanced electronics. | FactSet: Segment-level financial data and historical comparisons (if restated data is provided); AlphaSense: Keyword searches for 'Specialty Materials performance' in competitor transcripts. |
| High Performance Polymers (HPP) Volume & Mix Recovery | HPP is a key growth area within Arkema's Advanced Materials, driven by high-value applications in batteries, sports, and 3D printing. Its recovery from Q4 2025 destocking indicates underlying demand strength and improved profitability, especially in Europe and the U.S. | Observe organic growth rates for High Performance Polymers, particularly in Europe and the U.S., and management's commentary on destocking trends and inventory normalization in Q1 and Q2 2026 earnings calls. | Bullish: HPP organic growth accelerating (e.g., exceeding 2% YoY) with positive commentary on demand and inventory normalization in Europe/U.S. Bearish: Continued weak HPP volumes or negative geographical mix due to persistent destocking. | Company's quarterly earnings calls and presentations, specifically discussions on the Advanced Materials segment and High Performance Polymers. | Industry association reports on market growth for key HPP end markets like batteries, 3D printing, and advanced electronics. | YipitData: Supply chain checks for key HPP end markets (e.g., automotive, electronics production); Sensor Tower: App downloads for 3D printing software (indirect proxy). |
| Additional EBITDA Contribution from Major Projects | This factor indicates the successful execution and ramp-up of Arkema's strategic investments, directly contributing to future earnings. It validates the company's long-term growth strategy and its ability to deliver on capital expenditure initiatives. | Track management's updates on the incremental EBITDA contribution from major projects, such as the 1233zd/DMDS unit in the U.S., Rilsan Clear capacity in Singapore, and PVDF expansion in the U.S., against the EUR 50 million target for 2026. | Bullish: Project contribution exceeding EUR 50 million or faster-than-expected ramp-up and positive commentary on project momentum. Bearish: Project contribution falling short of EUR 50 million or significant delays in project ramp-up. | Company's quarterly and half-yearly earnings calls, investor presentations, and press releases. | Industry news and trade publications reporting on new chemical plant startups or capacity expansions in the U.S. and Asia for specialty polymers and fluorospecialties. | Wood Mackenzie: Global chemical capacity additions and utilization rates; ICIS: Market intelligence on specific chemical product prices and supply dynamics. |
Key Reported Metrics
| Metric | Why It Matters | Last Period |
|---|---|---|
| Group Total Sales | Total sales indicate market demand and pricing power. Given the reported 5% decline in 2025 and expectations of continued weak demand and destocking, this metric is crucial for assessing market conditions. | down 5% |
| Group EBITDA | This metric reflects overall profitability and operational efficiency. Investors will closely watch its performance against management's guidance for slight growth in 2026, especially given the challenging H1 and Q1 outlook. | -18.3% |
| Specialty Materials EBITDA (prior segmentation) | The new segmentation aims to highlight the resilience and growth of Specialty Materials. Its performance will validate the strategic shift and provide transparency on Arkema's core growth drivers in a volatile environment. | decreased 5% at constant FX |
Key QuestionsWill Arkema's EBITDA for Q1 2026, at constant exchange rates, show an improvement over Q4 2025 and align with the full-year guidance of 'slightly' growing EBITD
Will Arkema's EBITDA for Q1 2026, at constant exchange rates, show an improvement over Q4 2025 and align with the full-year guidance of 'slightly' growing EBITDA, despite the anticipated challenging H1?
- Question 2
How will the newly implemented 'Specialty Materials' segment perform in Q1 2026, specifically demonstrating resilience and growth in key markets like batteries, 3D printing, and new generation fluorospecialties, to offset the cyclicality of 'Primary Materials'?
- Question 3
Will the destocking trend in Europe and the U.S. for High Performance Polymers and construction end markets show signs of abating in Q1 2026, leading to a volume recovery, or will customer inventory cautiousness continue to weigh on demand?
Earnings Transcript Summary
· 2025FY Earnings Call
| 3 Things Management Is Most Focused On | Call Takeaway & Tone | Prior Quarter'S Y/Y Growth By Segment | 3 Things Analysts Most Pressed On (And Mgmt Responses) | Revenue Segments |
|---|---|---|---|---|
| 1. **Cost and Cash Initiatives**: Management is highly focused on optimizing fixed costs, variable costs, CapEx, and working capital, having delivered EUR 90 million in savings in 2025 and aiming to continue this work in 2026 to offset inflation and achieve cumulative cost savings targets ahead of schedule. 2. **Ramp-up of Major Projects and Strategic Investments**: The company is focused on the progressive ramp-up of recent investments in the U.S. and Asia, including new 1233zd and DMDS units, Rilsan Clear capacity, and PVDF expansion, expecting these projects to contribute around EUR 50 million of additional EBITDA in 2026. 3. **New Segmentation for Transparency and Portfolio Clarity**: Arkema is implementing a new segmentation starting in 2026 to better highlight the distinct dynamics of resilient and fast-growing Specialty Materials compared to more cyclical Primary Materials, aiming to provide greater transparency to the financial community. | The overall takeaway of the call is that Arkema navigated a very challenging macroeconomic environment in 2025, with group sales down 5% and a significant EBITDA decrease, yet delivered strong cash flow and achieved cost savings ahead of schedule. Management is proactively addressing portfolio clarity through a new segmentation to highlight the resilience of its Specialty Materials. The tone is cautious, acknowledging limited visibility and ongoing macro headwinds, particularly in H1 2026, but also confident in the company's strategic direction, cost control measures, and the long-term potential of its major projects and leadership positions in key markets. | Group Total Sales (Q3 2025): down 4.7% at constant exchange rates. Advanced Materials (Q3 2025): down 4.5% at constant exchange rates. High Performance Polymers volumes (within Advanced Materials, Q3 2025): stable. Coating Solutions (Q3 2025): decreased by 15.2% year-on-year. Adhesive Solutions (Q3 2025): Volumes reflected weak demand in Europe and the United States. Intermediates (Q3 2025): EBITDA impacted by seasonal decrease in refrigerant gases. | 1. **Construction End Markets and Working Capital**: Analysts questioned the step-down in U.S. construction in H2 2025, expectations for Europe in 2026, and how much of the strong Q4 free cash flow was due to working capital cuts, asking if working capital would need to increase with volume improvement in 2026. Management responded that Europe has 'reached certainly a bottom' with 'incremental improvement' to be confirmed, while the U.S. saw a decrease in H2 2025 but they 'would not extrapolate necessarily.' For working capital, it's expected to be 'flat working cap' in 2026 at constant macro, but 'should increase in a commensurate way' if there's a rebound. 2. **New Divisional Restatement/Structure**: Analysts challenged the new structure, suggesting it highlights a 'lack of industrial logic' and hurts investors' ability to track performance, also asking if management was open to exiting upstream acrylics plants. Management stated it's an 'incremental change' for 'better reading' and 'greater transparency' to highlight resilient Specialty Materials performance in a more volatile world. They confirmed acrylics remains a 'backbone' and 'not at all... the topic of disposal' for now, but 'there is never any taboo.' 3. **HPP Q4 Performance and Acrylics Outlook**: Analysts noted HPP's 'collapse down' in Q4 after stable Q2/Q3, asking about competitive pressures or commoditization risk, and also inquired about the outlook for EU/U.S. acrylics given capacity additions, expecting 'breakeven EBITDA for '26.' Management explained that HPP's Q4 decline was 'really driven by the destock of customer' in Europe and U.S., impacting geographical mix and profitability, not a 'new trend' of competition. For acrylics, they acknowledged the 'depth of the cycle' was surprising, expecting 'something not far from what we saw in '25' for 2026, with 'a little bit of improvement.' | Group Total Sales: down 5% year-on-year. High Performance Polymers (within Advanced Materials): 2% organic growth year-on-year. Advanced Materials (overall segment): broadly stable volumes and prices. Adhesives: Weak demand in industrial additives and U.S. slowdown impacted performance. Coatings: Low cycle conditions in upstream acrylics and weak demand impacted performance. Intermediates: Decline in refrigerants impacted performance. |
Transcript Tidbits
| About Expanding Eligible Market | About Competition | About The Broader Industry | Where Things Are Headed | Updates On Theme | Broader Themes Emerging | Bullish-Leaning Quotes (Short) | Bearish-Leaning Quotes (Short) | Hiring |
|---|---|---|---|---|---|---|---|---|
| Arkema is seeing an acceleration in electric mobility, advanced electronics, and sustainable consumer goods in Asia, particularly China. Key attractive markets like batteries, sports, 3D printing, healthcare, and new generation fluorospecialties with low global warming potential (GWP) are showing strong dynamics, with sales up 16% year-on-year. PIAM is becoming essential for new smartphones, including foldable and ultra-slim models, and is diversifying into new high-end industrial applications. New generation low GWP solutions are integrated into the fluorospecialties portfolio, benefiting from accelerated growth in applications like heat pumps and data centers. High Performance Polymers showed 2% organic growth, supported by new business developments in batteries, sports, 3D printing, and positive dynamics in Asia. | The company's EBITDA decrease in 2025 was not different from what most peers experienced. Arkema believes it is able to differentiate itself versus competition and precisely checks its market shares. There's a question about whether European authorities are more willing to help the sector regain competitiveness and protect against unfair competition, particularly from China. Management notes that authorities are more aware of the danger to industrial assets in Europe and are thinking more about competitiveness and protection, but "in terms of act for the time being, we see nothing." | 2025 was one of the most challenging macroeconomic environments for the industry in the last 20 years, marked by subdued demand and tight year-end inventory management. The chemical supply chain is complex, longer, and fragmented, making it difficult to get a clear view of inventory levels. Destocking has been ongoing for an extended period, surprising many, but stocks for most of the chain appear to be rather low. The industry is experiencing a typical chemical cycle where volumes and pricing amplify movements. The depth of the acrylics cycle has been surprising, comparable to 2010. | Arkema expects the challenging environment and limited visibility to continue into early 2026, with the macro environment in 2026 anticipated to be similar to 2025. The company aims for its EBITDA to grow slightly at constant FX in 2026, with major projects contributing around EUR 50 million additional EBITDA. The year-on-year comparison will be more challenging in H1, especially Q1, due to last year's profile and an estimated negative currency effect of EUR 25 million in Q1. Performance is expected to be more balanced between H1 and H2 in 2026 compared to 2025. CapEx will be reduced to EUR 600 million in 2026 to invest in high-return, fast-payback projects. The company will continue to focus on cost and cash optimization, aiming to deliver the 2028 cumulative cost savings target of EUR 250 million two years in advance. A new segmentation will be implemented in 2026 to provide greater transparency on Specialty Materials versus more cyclical Primary Materials. Working capital is expected to remain flat at constant macro, but would increase with a rebound in demand. | Chemicals | Increased volatility across various parameters (FX, macro figures, brand evolution) reinforcing the cyclical nature of some chemical segments. Growing awareness and intent from European authorities to protect industrial assets and enhance competitiveness against unfair competition, though concrete actions are yet to be seen. | "We generated a high level of cash at EUR 464 million, well above our revised guidance of EUR 300 million." "We should, therefore, be able to deliver the 2028 cumulative cost savings target of EUR 250 million, 2 years in advance." "The Board has decided to propose a stable dividend of EUR 3.60 per share... which is a sign of confidence." "for 2026, the group aims for its EBITDA to grow slightly at constant FX." "We really confirm the quality of the projects. They are all meaningful." | "In 2025, the macroeconomic environment was, as you know, particularly challenging, probably one of the most difficult our industry has faced in the last 20 years." "EBITDA stood indeed at EUR 1.25 billion... not living up to our expectation at the beginning of our year." "At the beginning of the year, the environment remains... with limited visibility and weak demand." "The currency effect... continues to be a headwind." "The year-on-year comparison will be more challenging in H1, and more particularly in Q1." "In terms of act for the time being, we see nothing." | The group implemented a headcount reduction of more than 2% in 2025 and anticipates a further reduction of around 3% per year over the next three years to make the organization more efficient. |
Notes
| Date | Comment | Comment Type | Comment Sentiment | Link | IS CHANGE | Price Reaction |
|---|---|---|---|---|---|---|
| 2026-02-26 | Arkema reported challenging 2025 results with €1.25B EBITDA, but strong €464M cash flow beat guidance. Significant cost savings and a new segmentation for transparency were highlighted. The 2026 outlook projects slight EBITDA growth. The stock outperformed post-earnings, reflecting market confidence in resilient cash generation, cost control, and strategic clarity despite a tough macro. | Other | Neutral | False | +2.74% (vs SPY: +3.72%) |
Upcoming Events
| Catalyst ID | Estimated Timing | Estimated Date Start | Estimated Date End | Catalyst | Why It Matters | Ticker Or Theme Specific | Transcript Date | Source Type |
|---|---|---|---|---|---|---|---|---|
| AKE.PA_e9038a17 | PVDF US start-up planned to start up in the first half of 2026 | 2026-01-01 | 2026-06-30 | Start-up of PVDF capacity in the United States, increasing regional capacity by 15%. | Catalyzes additional high-margin polymer production in a key market, with potential EBITDA uplift if ramp-up meets plan; delays or cost overruns could weigh on margins and timing of benefits. | Ticker | 2026-02-26 | earnings_transcript |
| AKE.PA_6ce71e07 | Ramping up major projects in 2026 contributing around EUR 50 million of additional EBITDA | 2026-01-01 | 2026-12-31 | Ramp-up of major projects (including 1233zd US, DMDS US, and Rilsan Clear in Singapore) expected to contribute ~EUR 50 million of additional EBITDA in 2026. | Represents a meaningful driver of near-term earnings and cash generation; if slower, it could temper guidance and investor sentiment. | Ticker | 2026-02-26 | earnings_transcript |
| AKE.PA_f2b1743e | Q1 2026 currency headwind of about EUR 25 million | 2026-01-01 | 2026-03-31 | Currency impact in Q1 2026 estimated at a negative EUR 25 million. | FX headwinds could dampen early-2026 earnings and offset improvements from volume/mix, influencing quarterly guidance and sentiment. | Ticker | 2026-02-26 | earnings_transcript |
| AKE.PA_9d5b5502 | 2028 cumulative cost savings target of EUR 250 million, 2 years in advance | 2028-01-01 | 2028-12-31 | Delivery of EUR 250 million in cost savings by 2028, achieved two years earlier than planned. | Material potential improvement to margins and cash flow, reducing sensitivity to input cost inflation and potentially supporting multiple expansion if achieved. | Ticker | 2026-02-26 | earnings_transcript |
| AKE.PA_543c78bb | starting in 2026 | 2026-01-01 | 2026-12-31 | Implementation of a new segmentation starting in 2026 to separate Specialty Materials from Primary Materials (including polyamide business) for better portfolio visibility. | Increases transparency for investors and could impact valuation/interpretation of segments; restructuring could affect reported metrics and investor perception. | Ticker | 2026-02-26 | earnings_transcript |